Related Experiment Video
Updated: Aug 6, 2026
09:12
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
Autoimmune Biliary Diseases: From Fragmented Pathways to Precision Diagnosis
Anthony Bedran1, Karim Hoyek2, Doha Houcheimy1
1Department of Internal Medicine, University of Balamand, Beirut, Lebanon.
Sage Open Pathology
|July 26, 2026
Summary
Diagnosing autoimmune biliary diseases like PSC and PBC is often delayed due to complex pathways and limited markers. An integrated diagnostic approach using advanced tools can improve accuracy and reduce misclassification.
Area of Science:
- Hepatology and Immunology
- Diagnostic Medicine
- Gastroenterology
Background:
- Autoimmune biliary diseases, including primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), and IgG4-related sclerosing cholangitis (IgG4-SC), contribute to chronic cholestatic liver disease.
- Diagnostic delays persist despite advanced imaging (MRCP) and serological tests due to fragmented pathways, variable marker sensitivity, and overlapping syndromes.
Purpose of the Study:
- To critically evaluate current diagnostic modalities for autoimmune biliary diseases.
- To propose an integrated, precision-layered, phenotype-defined, and tissue-informed diagnostic pathway for standardizing evaluation across autoimmune and immune-mediated cholangiopathies.
Main Methods:
- Synthesized evidence from major society guidelines (AASLD/EASL), key reviews, and pivotal studies.
- Extracted data on autoimmune serologies, MRCP (including advanced techniques), elastography/MRE for fibrosis staging, and endoscopic tissue diagnostics.
- Focused on overlap phenotypes, intermediate strictures, and malignancy exclusion.
Main Results:
- Diagnostic delays are significantly contributed by seronegative/atypical PBC, limited MRCP sensitivity in early or small-duct PSC, and misclassification of IgG4-SC as PSC.
- An iterative diagnostic escalation from serology to non-invasive ductal mapping, tissue clarification, and investigational tools (AI-assisted MRCP, molecular cytology, liquid biopsy) improves discrimination.
- These advanced tools aim to differentiate overlapping conditions and support risk-stratified surveillance.
Conclusions:
- Implementing a precision-layered, phenotype-defined, and tissue-informed diagnostic pathway can reduce diagnostic uncertainty and misclassification in autoimmune biliary diseases.
- This standardized approach aims to improve evaluation across the spectrum of autoimmune biliary conditions.
- Emerging diagnostic tools require prospective validation before routine clinical integration.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...